In addition to IL-6 [15, 80], recent studies show that IL-1 also plays an important role in CRS [81, 82], whereby an IL-1 receptor antagonist, (Anakinra) can effectively control CRS and neurotoxicity in humanized mice [81]. This evidence concerns the gene IL6 and congenital rubella syndrome.